Slowly progressive type 1 diabetes treated with metformin for five years after onset

Takumi Hirata, Akira Shimada, Jiro Morimoto, Taro Maruyama

研究成果: Article査読

3 被引用数 (Scopus)

抄録

A 52-year-old man was diagnosed with slowly progressive type 1 diabetes (SPIDDM). We expected him to quickly progress to an insulin-dependent state due to a high anti-glutamic acid decarboxylase antibody titer (23.9 U/mL). At SPIDDM diagnosis, he was in a non-insulin-dependent state, with a fasting serum C-peptide immunoreactivity level of 2.5 ng/mL. Therefore, we prescribed metformin. His glycemic control remained stable, and his intrinsic insulin secretion capacity was maintained for five years. Although one case is insufficient to draw firm conclusions, this report suggests that metformin is a therapeutic choice for SPIDDM when the insulin secretion capacity is maintained.

本文言語English
ページ(範囲)2635-2637
ページ数3
ジャーナルInternal Medicine
52
23
DOI
出版ステータスPublished - 2013 12 5
外部発表はい

ASJC Scopus subject areas

  • Internal Medicine

フィンガープリント 「Slowly progressive type 1 diabetes treated with metformin for five years after onset」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル